Pacific Arrow/Data Prospect Company Ltd. Hong Kong (4/17 -3/20)
“Determine the cellular effects of herbal drug X”
P.I. 71% efforts, total cost $348,000
Pacific Arrow/Data Prospect Company Ltd. Hong Kong (4/14 -3/17)
“Determine the cellular effects of herbal drug X”
P.I. 70% efforts, total cost $345,600
Pacific Arrow/Data Prospect Company Ltd. Hong Kong (4/11 -3/14)
“Determine the cellular effects of herbal drug X”
P.I. 70% efforts, total cost $333,445
Pacific Arrow/Data Prospect Company Ltd. Hong Kong (4/08 -3/11)
“Determine the cellular effects of herbal drug X”
P.I. 70% efforts, total cost $299,487
Data Prospect Company Ltd. Hong Kong (4/07 -3/08)
“Determine the cellular effects of herbal drug X”
P.I. 70% efforts, total cost $90,000
Data Prospect Company Ltd. Hong Kong (4/06 -3/07)
“Determine the cellular effects of herbal drug X”
P.I. 60% efforts, total cost $80,000
Data Prospect Company Ltd. Hong Kong (4/05 -3/06)
“Determine the cellular effects of herbal drug X”
P.I. 50% efforts, total cost $60,000
ELSA U. Pardee Foundation (5/03 – 6/05)
“Isolation of the synergistic ingredient for cancer chemotherapy in the herbal drug Fago-c”.
P.I. 32% efforts, total cost $75,000
Data Prospect Company Ltd. Hong Kong (10/03 -4/05)
“Determine the cellular effects of herbal drug X”
P.I. 30% efforts, total cost $60,000
VION Pharmaceuticals, Inc. (2001- 2003)
“Protein expression profiles of attenuated tumor-targeting Salmonella”
P.I., 10% effort, total cost $45,000
NIH R43 CA096292 (2/1/03 – 7/31/03)
(SBIR phase-1, VION Pharmaceuticals Inc.)
“Identification of Tumoricidal Components in Salmonella”
Co-PI, 30% efforts, total cost $49,261
International Herbal Pharmaceuticals, Corp. (2002)
“Studies of the molecular targets of fagopyrum cymosum”
P.I., 30% efforts, total cost $109,746
NIH 5 R01 CA 42476, (3/94-2/97, extended to 2/99)
"Drug Effects on Function of Phosphoprotein B23"
P.I., 60% effort, direct cost $351,592/3 years
Texas Higher Edu. Coordinating Board, ATP (1/94-8/96)
"An in vitro drug effect assay for cancer patients"
P.I., 20% effort, direct cost $163,567/2 years
NIH 5 R01 CA 42476, (4/89-3/94)
"Drug Effects on Function of Phosphoprotein B23"
P.I., 45% effort, direct cost $532,205/5 years
NIH 5 RO1 CA 42476, (4/86-3/89)
"Drug Effects on Function of Phosphoprotein B23"
P.I., 25% effort, direct cost $178,688/3 years
NIH 5 PO1 CA 10893, (8/85-7/87)
"Pharmacological Studies of Luzopeptin and Echinomycin.
Co-PI, 10% effort, direct cost $25,747/year
